Literature DB >> 21804913

Six degrees of separation: the oxygen effect in the development of radiosensitizers.

Bryan T Oronsky1, Susan J Knox, Jan Scicinski.   

Abstract

The popular theory six degrees of separation is used in this review as an analogy to relate all radiosensitization to oxygen. As the prime mover of all radiosensitizers, the pervasive influence of oxygen has consciously or unconsciously influenced the direction of research and development and provided the benchmark against which all other compounds and approaches are measured. It is the aim of this review to develop the six degrees of separation from oxygen analogy as a unifying framework for conceptually organizing the field and for giving context to its varied subspecializations and theories. Under such a framework, it would become possible for one area to consider questions and problems found in other areas of radiosensitization, using a common analogy, that would allow for further development and unification of this multifaceted discipline. In this review, approaches to the development of radiosensitizers and the current state of research in this field are discussed, including promising new agents in various stages of clinical development.

Entities:  

Year:  2011        PMID: 21804913      PMCID: PMC3140005          DOI: 10.1593/tlo.11166

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  119 in total

1.  Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.

Authors:  David L Schwartz; James A Bankson; Robert Lemos; Stephen Y Lai; Arun K Thittai; Yi He; Galen Hostetter; Michael J Demeure; Daniel D Von Hoff; Garth Powis
Journal:  Mol Cancer Ther       Date:  2010-06-29       Impact factor: 6.261

2.  Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.

Authors:  Lisa J Frederiksen; Richard Sullivan; Lori R Maxwell; Shannyn K Macdonald-Goodfellow; Michael A Adams; Brian M Bennett; D Robert Siemens; Charles H Graham
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

3.  Increasing survival of ischemic tissue by targeting CD47.

Authors:  Jeff S Isenberg; Martin J Romeo; Mones Abu-Asab; Maria Tsokos; Anna Oldenborg; Loretta Pappan; David A Wink; William A Frazier; David D Roberts
Journal:  Circ Res       Date:  2007-02-09       Impact factor: 17.367

4.  Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09.

Authors:  J H Schellens; A S Planting; B A van Acker; W J Loos; M de Boer-Dennert; M E van der Burg; I Koier; R T Krediet; G Stoter; J Verweij
Journal:  J Natl Cancer Inst       Date:  1994-06-15       Impact factor: 13.506

5.  SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.

Authors:  E M Zeman; J M Brown; M J Lemmon; V K Hirst; W W Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-07       Impact factor: 7.038

6.  Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin. A possible mechanism for neurotoxicity caused by nitroheterocyclic drugs.

Authors:  D N Rao; R P Mason
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

7.  IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

Authors:  I Tamm; Y Wang; E Sausville; D A Scudiero; N Vigna; T Oltersdorf; J C Reed
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

8.  MITOMYCINS AND PORFIROMYCIN: CHEMICAL MECHANISM OF ACTIVATION AND CROSS-LINKING OF DNA.

Authors:  V N IYER; W SZYBALSKI
Journal:  Science       Date:  1964-07-03       Impact factor: 47.728

9.  Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation.

Authors:  J M Brown; M J Lemmon
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-03       Impact factor: 7.038

Review 10.  AQ4N: a new approach to hypoxia-activated cancer chemotherapy.

Authors:  L H Patterson; S R McKeown
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  24 in total

1.  Electron stimulated desorption of anions from native and brominated single stranded oligonucleotide trimers.

Authors:  Katarzyna Polska; Janusz Rak; Andrew D Bass; Pierre Cloutier; Léon Sanche
Journal:  J Chem Phys       Date:  2012-02-21       Impact factor: 3.488

2.  The scarlet letter of alkylation: a mini review of selective alkylating agents.

Authors:  Bryan T Oronsky; Tony Reid; Susan J Knox; Jan J Scicinski
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243

3.  Is Nitric Oxide (NO) the Last Word in Radiosensitization? A Review.

Authors:  Bryan T Oronsky; Susan J Knox; Jan J Scicinski
Journal:  Transl Oncol       Date:  2012-04-01       Impact factor: 4.243

Review 4.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

5.  Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.

Authors:  Marcel H Fens; Pedro Cabrales; Jan Scicinski; Sandra K Larkin; Jung H Suh; Frans A Kuypers; Neil Oronsky; Michelle Lybeck; Arnold Oronsky; Bryan Oronsky
Journal:  Med Oncol       Date:  2016-07-04       Impact factor: 3.064

Review 6.  Hypoxia Imaging As a Guide for Hypoxia-Modulated and Hypoxia-Activated Therapy.

Authors:  Jeffrey R Brender; Yu Saida; Nallathamby Devasahayam; Murali C Krishna; Shun Kishimoto
Journal:  Antioxid Redox Signal       Date:  2022-01       Impact factor: 8.401

Review 7.  NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.

Authors:  Jan Scicinski; Bryan Oronsky; Shoucheng Ning; Susan Knox; Donna Peehl; Michelle M Kim; Peter Langecker; Gary Fanger
Journal:  Redox Biol       Date:  2015-07-02       Impact factor: 11.799

Review 8.  The implications of hyponitroxia in cancer.

Authors:  Bryan Oronsky; Gary R Fanger; Neil Oronsky; Susan Knox; Jan Scicinski
Journal:  Transl Oncol       Date:  2014-03-04       Impact factor: 4.243

9.  Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial.

Authors:  Michelle M Kim; Hemant Parmar; Yue Cao; Priyanka Pramanik; Matthew Schipper; James Hayman; Larry Junck; Aaron Mammoser; Jason Heth; Corey A Carter; Arnold Oronsky; Susan J Knox; Scott Caroen; Bryan Oronsky; Jan Scicinski; Theodore S Lawrence; Christopher D Lao
Journal:  Transl Oncol       Date:  2016-04       Impact factor: 4.243

10.  Carbogen gas and radiotherapy outcomes in prostate cancer.

Authors:  Kent Yip; Roberto Alonzi
Journal:  Ther Adv Urol       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.